Skip to content. | Skip to navigation

Garvan Institute

Sections
 

Pancreatic Cancer

 

Pancreatic cancer is the fifth leading cause of cancer death in Western societies, with a five year survival rate of less than 10%. The treatment and survival of patients with pancreatic cancer has not changed for over thirty years because there has been little research into the molecular and cell biology associated with it. Our projects focus on understanding the role of retinoic acid signalling pathways in pancreatic cancer and defining new diagnostic and treatment strategies that may extend the successful use of retinoids seen in leukemia and skin cancer to pancreatic cancer. 

Staff

 

Senior Research Officer
Dr Chris Scarlett

Amanda MawsonResearch Assistant
Amanda Mawson

Mark PineseResearch Assistant
Mark Pinese


Johana SusantoPhD Student
Johana Susanto

Amber JohnsClinical Research Coordinator
Amber Johns
Emily ColvinPostgraduate Student
Emily Colvin
PhD Student
David Chang
Visiting Scientists
Dr Peter Cosman
A/Prof James Kench
A/Prof Neil Merritt
Dr Nam Quoc Nguyen
Dr Chelsea O'Connor
Data Clerks
Natalie Purcell
Michelle Thomas
Bronwyn Thorp

News

 

Emily Colvin wins Premier’s Award for Outstanding Cancer Research Scholar

26 May 2009
Garvan PhD student Emily Colvin has received the prestigious $10,000 Premier's Award for Outstanding Cancer Research Scholar from the Cancer Institute NSW for her research into pancreatic cancer. The news was announced at a gala ceremony late last week.
 
 

Nuns on the Run from Dubbo to Darlinghurst for Cancer

MEDIA RELEASE: 19 Apr 2009
Led by two Sisters of Charity, The Nuns’ Run will cover the 400 km distance from Dubbo to Darlinghurst in an effort to raise cancer awareness and crucial funds for the establishment of a new $100 million Cancer Centre within the St Vincent’s Research Precinct, Sydney. Embarking on their journey on 24 May, Sisters Helen Clarke and Leone Wittmack are hoping to arrive in Sydney on 5 June.
 
 

Garvan to play a role in International Cancer Genome Consortium

MEDIA RELEASE: 26 Mar 2009
Garvan scientists will play an integral role in Australia’s contribution towards the International Cancer Genome Consortium, the details of which were announced today by Minister for Health and Ageing, The Hon. Nicola Roxon MP. They will be part of a team tackling pancreatic cancer, one of the deadliest cancers.
 
 

Personal tools